Publication of revisions to the Guidance Document - Patented Medicines (Notice of Compliance) Regulations: Notice

January 14, 2025
Our reference number: 24-111982-628

Health Canada is pleased to announce an update to the Guidance Document: Patented Medicines (Notice of Compliance) Regulations.

The Office of Patented Medicines and Liaison, within the Office of Submissions and Intellectual Property, Health Products and Food Branch, administers the Patented Medicines (Notice of Compliance) Regulations.

The Guidance Document has been amended to align with existing Health Products and Food Branch policies and the Office of Patented Medicines and Liaison's current practices as they relate to the administration of the Patented Medicines (Notice of Compliance) Regulations.

Questions or concerns related to this Guidance Document should be directed to the Office of Patented Medicines and Liaison by e-mail at: opml-bmbl@hc-sc.gc.ca